AF1L2_HUMAN - dbPTM
AF1L2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID AF1L2_HUMAN
UniProt AC Q8N4X5
Protein Name Actin filament-associated protein 1-like 2
Gene Name AFAP1L2
Organism Homo sapiens (Human).
Sequence Length 818
Subcellular Localization Cytoplasm .
Protein Description May play a role in a signaling cascade by enhancing the kinase activity of SRC. Contributes to SRC-regulated transcription activation..
Protein Sequence MERYKALEQLLTELDDFLKILDQENLSSTALVKKSCLAELLRLYTKSSSSDEEYIYMNKVTINKQQNAESQGKAPEEQGLLPNGEPSQHSSAPQKSLPDLPPPKMIPERKQLAIPKTESPEGYYEEAEPYDTSLNEDGEAVSSSYESYDEEDGSKGKSAPYQWPSPEAGIELMRDARICAFLWRKKWLGQWAKQLCVIKDNRLLCYKSSKDHSPQLDVNLLGSSVIHKEKQVRKKEHKLKITPMNADVIVLGLQSKDQAEQWLRVIQEVSGLPSEGASEGNQYTPDAQRFNCQKPDIAEKYLSASEYGSSVDGHPEVPETKDVKKKCSAGLKLSNLMNLGRKKSTSLEPVERSLETSSYLNVLVNSQWKSRWCSVRDNHLHFYQDRNRSKVAQQPLSLVGCEVVPDPSPDHLYSFRILHKGEELAKLEAKSSEEMGHWLGLLLSESGSKTDPEEFTYDYVDADRVSCIVSAAKNSLLLMQRKFSEPNTYIDGLPSQDRQEELYDDVDLSELTAAVEPTEEATPVADDPNERESDRVYLDLTPVKSFLHGPSSAQAQASSPTLSCLDNATEALPADSGPGPTPDEPCIKCPENLGEQQLESLEPEDPSLRITTVKIQTEQQRISFPPSCPDAVVATPPGASPPVKDRLRVTSAEIKLGKNRTEAEVKRYTEEKERLEKKKEEIRGHLAQLRKEKRELKETLLKCTDKEVLASLEQKLKEIDEECRGEESRRVDLELSIMEVKDNLKKAEAGPVTLGTTVDTTHLENVSPRPKAVTPASAPDCTPVNSATTLKNRPLSVVVTGKGTVLQKAKEWEKKGAS
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
332-HydroxyisobutyrylationLSSTALVKKSCLAEL
CCCCHHHHHHHHHHH
39.56-
44PhosphorylationLAELLRLYTKSSSSD
HHHHHHHHHCCCCCC
12.9927273156
47PhosphorylationLLRLYTKSSSSDEEY
HHHHHHCCCCCCCCE
27.8726356563
48PhosphorylationLRLYTKSSSSDEEYI
HHHHHCCCCCCCCEE
35.1026356563
49PhosphorylationRLYTKSSSSDEEYIY
HHHHCCCCCCCCEEE
49.2326356563
50PhosphorylationLYTKSSSSDEEYIYM
HHHCCCCCCCCEEEE
51.4926356563
54PhosphorylationSSSSDEEYIYMNKVT
CCCCCCCEEEEEEEE
8.7019060924
56PhosphorylationSSDEEYIYMNKVTIN
CCCCCEEEEEEEEEC
8.1727273156
61PhosphorylationYIYMNKVTINKQQNA
EEEEEEEEECCCCCH
22.0526356563
96PhosphorylationHSSAPQKSLPDLPPP
CCCCCCCCCCCCCCC
39.6328348404
119PhosphorylationLAIPKTESPEGYYEE
CCCCCCCCCCCCCCC
33.229449045
124PhosphorylationTESPEGYYEEAEPYD
CCCCCCCCCCCCCCC
20.39138541
158PhosphorylationEDGSKGKSAPYQWPS
CCCCCCCCCCCCCCC
43.0525106551
161PhosphorylationSKGKSAPYQWPSPEA
CCCCCCCCCCCCHHH
23.9525106551
165PhosphorylationSAPYQWPSPEAGIEL
CCCCCCCCHHHHHHH
32.2022777824
208PhosphorylationNRLLCYKSSKDHSPQ
CEEEEEECCCCCCCC
19.0223312004
209PhosphorylationRLLCYKSSKDHSPQL
EEEEEECCCCCCCCC
37.6423312004
213PhosphorylationYKSSKDHSPQLDVNL
EECCCCCCCCCCHHH
25.1925056879
223PhosphorylationLDVNLLGSSVIHKEK
CCHHHHCHHHHCHHH
22.7723312004
224PhosphorylationDVNLLGSSVIHKEKQ
CHHHHCHHHHCHHHH
24.2423312004
278PhosphorylationGLPSEGASEGNQYTP
CCCCCCCCCCCCCCC
57.8228348404
283PhosphorylationGASEGNQYTPDAQRF
CCCCCCCCCCCHHHH
25.0027251275
284PhosphorylationASEGNQYTPDAQRFN
CCCCCCCCCCHHHHC
12.6225056879
301PhosphorylationKPDIAEKYLSASEYG
CCHHHHHHCCHHHHC
9.4423090842
303PhosphorylationDIAEKYLSASEYGSS
HHHHHHCCHHHHCCC
27.0225394399
305PhosphorylationAEKYLSASEYGSSVD
HHHHCCHHHHCCCCC
28.1625106551
307PhosphorylationKYLSASEYGSSVDGH
HHCCHHHHCCCCCCC
21.5825394399
309PhosphorylationLSASEYGSSVDGHPE
CCHHHHCCCCCCCCC
26.7025106551
310PhosphorylationSASEYGSSVDGHPEV
CHHHHCCCCCCCCCC
21.6223090842
320PhosphorylationGHPEVPETKDVKKKC
CCCCCCCCCCHHHHH
26.8627307780
332MethylationKKCSAGLKLSNLMNL
HHHCCCCHHHHHHHC
49.29-
334PhosphorylationCSAGLKLSNLMNLGR
HCCCCHHHHHHHCCC
26.74101663561
344PhosphorylationMNLGRKKSTSLEPVE
HHCCCCCCCCCCCCH
26.6829255136
345PhosphorylationNLGRKKSTSLEPVER
HCCCCCCCCCCCCHH
46.3329255136
346PhosphorylationLGRKKSTSLEPVERS
CCCCCCCCCCCCHHH
37.5129255136
353PhosphorylationSLEPVERSLETSSYL
CCCCCHHHHHCHHHH
19.6328442448
356PhosphorylationPVERSLETSSYLNVL
CCHHHHHCHHHHHHH
28.4128442448
357PhosphorylationVERSLETSSYLNVLV
CHHHHHCHHHHHHHH
13.9628442448
358PhosphorylationERSLETSSYLNVLVN
HHHHHCHHHHHHHHC
40.8524872395
359PhosphorylationRSLETSSYLNVLVNS
HHHHCHHHHHHHHCC
11.3227259358
383PhosphorylationRDNHLHFYQDRNRSK
HHCCEEEEECCCCHH
9.9621082442
397PhosphorylationKVAQQPLSLVGCEVV
HHCCCCHHHCCCEEC
27.9126356563
408PhosphorylationCEVVPDPSPDHLYSF
CEECCCCCCCCEEEE
50.7929255136
413PhosphorylationDPSPDHLYSFRILHK
CCCCCCEEEEEEEEC
11.4429255136
414PhosphorylationPSPDHLYSFRILHKG
CCCCCEEEEEEEECC
17.8929255136
431PhosphorylationLAKLEAKSSEEMGHW
HHHHCCCCHHHHHHH
50.4550563843
432PhosphorylationAKLEAKSSEEMGHWL
HHHCCCCHHHHHHHH
36.5550563851
456PhosphorylationKTDPEEFTYDYVDAD
CCCHHHHCCCEECHH
20.8230814731
457PhosphorylationTDPEEFTYDYVDADR
CCHHHHCCCEECHHH
15.5925106551
459PhosphorylationPEEFTYDYVDADRVS
HHHHCCCEECHHHHH
6.9925348954
466PhosphorylationYVDADRVSCIVSAAK
EECHHHHHHHHHHHH
10.0630835091
470PhosphorylationDRVSCIVSAAKNSLL
HHHHHHHHHHHHHHH
11.5525348954
484PhosphorylationLLMQRKFSEPNTYID
HHHHHHCCCCCCCCC
56.0028355574
488PhosphorylationRKFSEPNTYIDGLPS
HHCCCCCCCCCCCCC
32.3530108239
489PhosphorylationKFSEPNTYIDGLPSQ
HCCCCCCCCCCCCCH
12.0330108239
537PhosphorylationERESDRVYLDLTPVK
CCCCCCEEEECCCCH
8.7325394399
541PhosphorylationDRVYLDLTPVKSFLH
CCEEEECCCCHHHHC
26.2119664994
545PhosphorylationLDLTPVKSFLHGPSS
EECCCCHHHHCCCCC
33.0230206219
551PhosphorylationKSFLHGPSSAQAQAS
HHHHCCCCCHHHHCC
42.7928387310
552PhosphorylationSFLHGPSSAQAQASS
HHHCCCCCHHHHCCC
27.7730206219
558PhosphorylationSSAQAQASSPTLSCL
CCHHHHCCCCCCHHH
25.4428857561
559PhosphorylationSAQAQASSPTLSCLD
CHHHHCCCCCCHHHH
25.5628857561
561PhosphorylationQAQASSPTLSCLDNA
HHHCCCCCCHHHHCH
33.0028857561
563PhosphorylationQASSPTLSCLDNATE
HCCCCCCHHHHCHHH
18.3430206219
569PhosphorylationLSCLDNATEALPADS
CHHHHCHHHCCCCCC
28.2225002506
576PhosphorylationTEALPADSGPGPTPD
HHCCCCCCCCCCCCC
49.3325002506
600PhosphorylationLGEQQLESLEPEDPS
CCHHHHHHCCCCCCC
46.77113326983
617PhosphorylationITTVKIQTEQQRISF
EEEEEEEECHHCCCC
38.9523312004
623PhosphorylationQTEQQRISFPPSCPD
EECHHCCCCCCCCCC
33.6123312004
627PhosphorylationQRISFPPSCPDAVVA
HCCCCCCCCCCCEEE
38.2228102081
635PhosphorylationCPDAVVATPPGASPP
CCCCEEECCCCCCCC
20.5722777824
640PhosphorylationVATPPGASPPVKDRL
EECCCCCCCCHHHHE
35.3329255136
650PhosphorylationVKDRLRVTSAEIKLG
HHHHEEEEHEEEECC
18.7827794612
651PhosphorylationKDRLRVTSAEIKLGK
HHHEEEEHEEEECCC
22.5054886155
668PhosphorylationTEAEVKRYTEEKERL
CHHHHHHHHHHHHHH
16.8872499757
669PhosphorylationEAEVKRYTEEKERLE
HHHHHHHHHHHHHHH
41.5272499763
697AcetylationRKEKRELKETLLKCT
HHHHHHHHHHHHHCC
43.8518527893
728PhosphorylationEECRGEESRRVDLEL
HHHCCCHHHCCCEEE
22.5329449344
736PhosphorylationRRVDLELSIMEVKDN
HCCCEEEEEEEHHHH
15.5424505115
753PhosphorylationKAEAGPVTLGTTVDT
HHCCCCEEECCEEEC
23.7023312004
756PhosphorylationAGPVTLGTTVDTTHL
CCCEEECCEEECCCH
27.1028348404
757PhosphorylationGPVTLGTTVDTTHLE
CCEEECCEEECCCHH
18.0028348404
760PhosphorylationTLGTTVDTTHLENVS
EECCEEECCCHHCCC
16.2728348404
761O-linked_GlycosylationLGTTVDTTHLENVSP
ECCEEECCCHHCCCC
21.7230379171
761PhosphorylationLGTTVDTTHLENVSP
ECCEEECCCHHCCCC
21.7228348404
767PhosphorylationTTHLENVSPRPKAVT
CCCHHCCCCCCCCCC
27.1225850435
774PhosphorylationSPRPKAVTPASAPDC
CCCCCCCCCCCCCCC
20.2810401181
788PhosphorylationCTPVNSATTLKNRPL
CCCCCCCCCCCCCCC
32.2710401193
796PhosphorylationTLKNRPLSVVVTGKG
CCCCCCCEEEEECCC
18.6228731282
800PhosphorylationRPLSVVVTGKGTVLQ
CCCEEEEECCCCHHH
22.9023312004
804PhosphorylationVVVTGKGTVLQKAKE
EEEECCCCHHHHHHH
22.8723312004

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
54YPhosphorylationKinaseRETP07949
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of AF1L2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of AF1L2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
A4_HUMANAPPphysical
21832049

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of AF1L2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
J. Proteome Res. 6:4150-4162(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-668 AND THR-669, ANDMASS SPECTROMETRY.
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells.";
Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.;
J. Proteome Res. 8:3852-3861(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-413, AND MASSSPECTROMETRY.
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer.";
Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
Cell 131:1190-1203(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-383 AND TYR-413, ANDMASS SPECTROMETRY.
"Time-resolved mass spectrometry of tyrosine phosphorylation sites inthe epidermal growth factor receptor signaling network reveals dynamicmodules.";
Zhang Y., Wolf-Yadlin A., Ross P.L., Pappin D.J., Rush J.,Lauffenburger D.A., White F.M.;
Mol. Cell. Proteomics 4:1240-1250(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-413, AND MASSSPECTROMETRY.

TOP